Any cranberry product vs placebo or control
Any cranberry product showed no clear difference in gastrointestinal adverse events compared with placebo or control (moderate certainty).
- RR 1.33 [1, 1.77]10 studies · 2166 participantsModerate
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Any cranberry product showed no clear difference in gastrointestinal adverse events compared with placebo or control (moderate certainty).
Phenobarbital showed no clear difference in IVH any grade (Papile classification) during hospitalisation compared with control (low certainty).
Phenobarbital showed no clear difference in severe IVH (Papile classification) during hospitalisation compared with control (low certainty).
It is very uncertain whether phenobarbital changes ventricular dilation or hydrocephalus during hospitalisation compared with control (very low certainty).
It is very uncertain whether phenobarbital changes mild neurodevelopmental impairment at 27 months of age compared with control (very low certainty).
It is very uncertain whether phenobarbital changes severe neurodevelopmental impairment at 9 to 27 months of age compared with control (very low certainty).
Phenobarbital showed no clear difference in death before discharge compared with control (low certainty).
Phenobarbital showed no clear difference in all deaths during the study compared with control (low certainty).
Non‐invasive brain stimulation showed no clear difference in adverse events: all ‐ central nervous system events (e.g. confusion,… compared with sham non‐invasive brain stimulation and/or usual care (low certainty).
Non‐invasive brain stimulation showed no clear difference in adverse events: all ‐ other events ‐ not listed above (e.g. dysuria,… compared with sham non‐invasive brain stimulation and/or usual care (low certainty).
It is very uncertain whether psychological therapy changes adverse events: death ‐ at end of treatment (secondary outcome) compared with usual care and/or attention control (very low certainty).
It is very uncertain whether psychological therapy changes adverse events: all ‐ central nervous system events (e.g. suicidal… compared with usual care and/or attention control (very low certainty).
It is very uncertain whether psychological therapy changes adverse events: all ‐ other events ‐ not listed above (e.g. fall,… compared with usual care and/or attention control (very low certainty).
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: death (secondary outcome) compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ central nervous system events (e.g. headache,… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ other events ‐ not listed above (e.g.… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
It is very uncertain whether pharmacological interventions changes adverse events: death (secondary outcome) compared with placebo (very low certainty).